[ 2 ] Pallu S, Francin PJ, Guillaume C, et al. Obesity affects the chondrocyte responsiveness to leptin in patients with osteoarthritis [J]. Arthritis Res Ther, 2010, 12(3): 112.
[3]
[ 3 ] Muller-Fassbender H, Bach GL, Haase W, et al. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee [J]. Osteoarthr Cartil,1994, 2(1): 61-69.
[4]
[ 4 ] Pavelka K, Gatterova J, Olejarova M, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3 year, randomized, placebo-controlled, double-blind study [J]. Arch Intern Med, 2002, 162(18): 2113-2123.
[5]
[ 5 ] Bassleer C, Rovati L, Franchimont P. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro [J]. Osteoarthr Cartil, 1998, 6(6): 427-434.
[ 7 ] Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patientrelevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee [J]. J Rheumatol 1988, 15(12):1833-1840.
[8]
[ 8 ] Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a andomized, placebo-controlled clinical trial [J]. Lancet, 2001, 357 (9252): 251-256.
[9]
[ 9 ] Uebelhart D, Malaise M, Marcolongo R, et al. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo [J]. Osteoarthr Cartil, 2004, 12(4): 269-276.
[10]
Michel BA, Stucki G, Frey D, et al. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial [J]. Arthritis Rheum, 2005, 52(3): 779-786.
[11]
Shikhman AR, Amiel D, D’Lima D, et al. Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis [J]. Ann Rheum Dis, 2005, 64(1): 89-94.
[12]
Chan PS, Caron JP, Rosa GJ, et al. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E2 in articular cartilage explants [J]. Osteoarthr Cartil, 2005, 13(5): 387-394.
[13]
Largo R, Alvarez-Soria MA, Diez-Ortego I, et al. Glucosamine inhibits IL-1beta-induced N fkappa B activation in human osteoarthritic chondrocytes [J]. Osteoarthr Cartil, 2003, 11(4): 290-298.
[14]
Raiss R. Effect of D-glucosamine sulfate on experimentally injured articular cartilage. Comparative morphometry of the ultrastructure of chondrocytes [J]. Fortschr Med, 1985, 103(24): 658-662.
Cibere J, Kopec JA, Thorne A, et al. Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis [J]. Arthritis Rheum, 2004, 51(5): 738-745.
[17]
Hughes R, Carr A. A randomized double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee [J]. Rheumatology (Oxford), 2002, 41(3): 279-284.
[18]
Cibere J, Thorne A, Kopec JA, et al. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers [J]. J Rheumatol, 2005, 32(5): 896-902.
[19]
Aghazadeh-Habashi A, Jamali F. The glucosamine controversy: a pharmacokinetic issue [J]. J Pharm Pharm Sci, 2011, 14(2): 264-273.
[20]
Laverty S, Sandy JD, Celeste C, et al. Synovial uid levels and serum pharmaco-kinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses [J]. Arthritis Rheum, 2005, 52(1): 181-191.
[21]
Biggee BA, Blinn CM, McAlindon TE, et al. Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness [J]. Ann Rheum Dis, 2006, 65(2): 222-226.
[22]
Glucosamine: reports of allergic skin reactions [R]. Austalian adverse drug reaction bulletin, 2005, 24 (6): 231.
